Renal immunocytochemical distribution and pharmacological properties of the dual angiotensin II/AVP receptor

Hypertension

Volumn 29, Issue 4, 1997, Pages 957-961

  Gonzalez, Carlos B ^a   Herrera, Victoria L M ^c   Ruiz Opazo, Nelson ^b  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

membrane proteins; renin angiotensin system; sodium; water electrolyte balance

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ADENYLATE CYCLASE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; ARGIPRESSIN; ARGIPRESSIN RECEPTOR; LOSARTAN; MEMBRANE PROTEIN;

ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CELLULAR DISTRIBUTION; DRUG RECEPTOR BINDING; ELECTROLYTE BALANCE; IMMUNOCYTOCHEMISTRY; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM ABSORPTION; SODIUM BALANCE; WATER ABSORPTION;

EID: 0031000892     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.4.957     Document Type: Article

References (33)

1. Capponi AM, Aguilera G, Fakunding JL, Catt KJ. Angiotensin II: receptors and mechanisms of action. In: Soffer RL, ed. Biochemical Regulation of Blood Pressure. New York, NY: John Wiley & Sons; 1981:205-262.
2. Douglas JG. Angiotensin receptor subtypes of the kidney cortex. Am J Physiol. 1987;253:F1-F7.
3. Gash DH, Boer GJ, eds. Vasopressin: Principles and Properties. New York, NY: Plenum Press; 1987.
4. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P, Rosenthal W. Molecular cloning of the receptor for human antidiuretic hormone. Nature. 1992;356: 333-335.
5. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993;268:24543-24546.
6. 2 receptor and possible link to nephrogenic diabetes insipidus. Nature. 1992;357:336-339.
7. 1a arginine vasopressin receptor. Nature. 1992;356:532-536.
8. Mukoyama M, Nakajima N, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 1993;268:5439-5442.
9. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
10. Ruiz-Opazo N, Akimoto K, Herrera VLM. Identification of a novel dual angiotensin II/vasopressin receptor on the basis of molecular recognition theory. Nature Medicine. 1995;1:1074-1081.
11. Sandberg K, Ji H, Clark AJL, Shapira H, Catt KJ. Cloning and expression of a novel angiotensin II receptor subtype. J Biol Chem. 1992;267:9455-9458.
12. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 1991;351:230-233.
13. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem. 1994;269:27088-27092.
14. Smith RD, Chiu AT, Wong PC, Herblin WF, Timmermans PBMWM. Pharmacology of nonpeptide angiotensin II receptor antagonist. Annu Rev Pharmacol Toxicol. 1992;32:135-165.
15. Jard S. Vasopressin isoreceptors in mammals: relation to cyclic AMP-dependent and cyclic AMP-independent transduction mechanisms. Curr Top Membr Transp. 1983;18:255-285.
16. Hedge GA, Hoffman LJ. Vasopressin and endocrine function. In: Gash DH, Boer GJ, eds. Vasopressin: Principles and Properties. New-York, NY: Plenum Press; 1987:435-475.
17. Phillipson OT, Gonzalez CB. Distribution of axons showing neurophysin-like immunoreactivity in cortical and anterior basal forebrain sites. Brain Res. 1983;258:33-44.
18. Manning M, Balaspiri L, Acosta M, Sawyer WH. Solid phase synthesis of [1-deamino,4-valine]-8-arginine vasopressin (DVDAVP), a highly potent and specific antidiuretic agent possessing protracted effects. J Med Chem. 1973;16:975-978.
19. Kruszynski M, Lammek B, Manning M. 1-(β-Mercapto-β,β-cyclopentamethylenepropionic acid)], 2-(O-methyl)tyrosine]arginine-vasopressin and [1-(β-mercapto-β,β-cyclopentamethylenepropionic acid)] arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine vasopressin. J Med Chem. 1980;23: 364-368.
20. Dudley DT, Panek RL, Major TC, Lu GH, Burns RF, Klinkefus BA, Hodges JC, Weishaar RE. Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol. 1990;38: 370-377.
21. Morel F, Imbert-Teboul M, Chabardes D. Receptors to vasopressin and other hormones in the mammalian kidney. Kidney Int. 1987;31: 512-520.
22. Barraclough MA, Jones NF, Marsden CD. Effect of angiotensin on renal function in the rat. Am J Physiol. 1967;212:1153-1157.
23. Hall JE. Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol. 1986;250: R960-R972.
24. Harris PJ, Young JA. Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption bv angiotensin II in the rat kidney. Pflugers Arch. 1977;367:295-297.
25. Harris PJ, Navar LG. Tubular transport responses to angiotensin. Am J Physiol. 1985;248:F621-F630.
26. Johnson MD, Malvin RL. Stimulation of renal sodium reabsorption by angiotensin II. Am J Physiol. 1977;232:F298-F306.
27. Mitchell KD, Navar LG. Interactive effects of angiotensin II on renal hemodynamics and tubular reabsorptive function. Kidney Int. 1990;38(suppl 30):569-573.
28. Navar LG, Langford HG. Effects of angiotensin on the renal circulation. In: Page IH, Bumpus FM, eds. Angiotensin, 1974. Handbuch der exp Pharmakol. Berlin, Germany: Springer-Verlag; 1974:455-474.
29. 2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain. Endocrinology: 1992;131:533-535.
30. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature. 1995;377:744-747.
31. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
32. Ito M, Oliviero MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A. 1995;92: 3521-3525.
33. Manning M, Nawrocka E, Misicka A, Olma A, Klis WA, Seto J, Sawyer WH. Potent and selective antagonists of the antidiuretic responses to arginine vasopressin based on modifications of [1,(β-mercapto-β,β-pentamethylenepropionic acid), 2-D-isoleucine, 4-valine],arginine-vasopressin at position 4. J Med Chem. 1984;27: 423-429.